Will you be recommending relugolix due to rapid suppression of testosterone and lower risk of cardiovascular events?

Once FDA approved, it will be an option; but I'm not sure what the cost to the patient will be, as it is an oral drug and that may be a limiting factor.

We still have the option of monthly degarelix if one is looking for a GnRH antagonist.